Search by Drug Name or NDC

    NDC 00409-6778-02 Lorazepam 2 mg/mL Details

    Lorazepam 2 mg/mL

    Lorazepam is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is LORAZEPAM.

    Product Information

    NDC 00409-6778
    Product ID 0409-6778_2d57bb95-a84e-42ea-bc7c-371cc15be95e
    Associated GPIs 57100060002005
    GCN Sequence Number 003755
    GCN Sequence Number Description lorazepam VIAL 2 MG/ML INJECTION
    HIC3 H21
    HIC3 Description SEDATIVE-HYPNOTICS - BENZODIAZEPINES
    GCN 14140
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Generic
    Proprietary Name Lorazepam
    Proprietary Name Suffix n/a
    Non-Proprietary Name LORAZEPAM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name LORAZEPAM
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA074282
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-6778-02 (00409677802)

    NDC Package Code 0409-6778-02
    Billing NDC 00409677802
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-6778-02) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-6778-11)
    Marketing Start Date 2006-01-31
    NDC Exclude Flag N
    Pricing Information N/A